UTILISATION DE MÉTABOLITES DU MICROBIOTE POUR DIFFÉRENCIER DES LYMPHOCYTES T NAÏFS ET PROCÉDÉS ASSOCIÉS D'INDUCTION OU DE PRÉVENTION DES AFFECTIONS INFLAMMATOIRES
The Texas A&M University System;Trustees of Tufts College
发明人:
ALANIZ, Robert, C.,JAYARAMAN, Arul,LEE, Kyongbum
申请号：
EP17767631
公开号：
EP3430128A4
申请日:
2017.03.17
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
This disclosure relates to methods and compositions for addressing conditions of dysbiosis and/or inflammation, such as enteropathy, associated with administration of non-steroidal anti-inflammatory drug (NSAID). The disclosure includes methods comprising administering an effective amount of a tryptophan derived microbiota metabolite (TDMM) to a subject that has also been administered, or is expected to have administered, a NSAID.
